Latest Roche News & Updates
See the latest news and media coverage for Roche. We track all announcements, press releases, and industry mentions in real time, all in one place.
Pharmaceuticals and diagnostics company
roche.com- Headquarters
- Switzerland 🇨🇭 , Switzerland
- Company type
- Public company
- Number of employees
- 100,000+
Last updated
Latest news about Roche
In short: Roche achieved 6% Q1 sales growth, advanced its obesity pipeline, and expanded its diagnostics portfolio through the $595 million Saga acquisition.
Company announcements
-
Roche enters definitive agreement to acquire PathAI
The transaction values the target at $750 million upfront plus up to $300 million in milestones. Closing is expected in the second half of 2026 and requires regulatory approvals.
-
Roche presents ophthalmology data at ARVO 2026
New real-world data confirm Vabysmo’s retinal drying in nAMD and DME. Key Susvimo data show lasting disease control. Over 45 abstracts across five retinal conditions.
-
Roche ranks among LinkedIn’s Top Companies 2026
It secures #4 in Singapore, #6 in Germany, #12 in Australia, and #30 in the U.S. The recognition credits its 100,000+ colleagues worldwide.
-
Roche shares strong Q1 2026 start
Results reflect growth, innovation commitment, and employee dedication. CEO Thomas Schinecker provides perspective.
Media coverage
-
Roche Holding AG (RHHBY) Stock Climbs on $750M PathAI Deal to Advance AI-Driven Cancer Diagnostics
Roche (RHHBY) stock rises 1.55% following announcement of PathAI acquisition for $750M, enhancing AI-powered cancer diagnostics and digital pathology capabilities.
-
Switzerland s Roche agrees to acquire US-based PathAI
Swiss pharmaceutical giant Roche said on Thursday it had agreed to acquire U.S.-based digital patho...
-
Roche reveals first data with Carmot-sourced oral GLP-1 drug
Roche has reported early-stage clinical data with an oral GLP-1 agonist acquired as part of its $3.1 billion takeover of Carmot Therapeutics as it tries...
-
Zealand Pharma and Roche to advance petrelintide, an amylin analog, to Phase 3 trials for chronic weight management
No. 11 / 2026 Zealand Pharma and Roche to advance petrelintide, an amylin analog, to Phase 3 trials for chronic weight ...
Track Roche and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore